China’s Kangtai starts mid-stage trial of its COVID-19 vaccine candidate

China’s Shenzhen Kangtai Biological Products has begun a mid-stage human trial of its experimental coronavirus vaccine, clinical trial registry data shows. Kangtai’s candidate is among more than 10 …
( read original story …)